These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2823434)

  • 1. Impact of cytomegalovirus infection and HLA-matching on outcome of renal transplantation.
    Waltzer WC; Arnold AN; Anaise D; Hurley S; Raisbeck A; Egelandsdsdal B; Pullis C; Rapaport FT
    Transplant Proc; 1987 Oct; 19(5):4077-80. PubMed ID: 2823434
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cytomegalovirus on renal transplantation.
    May AG; Betts RF; Andrus CC; Freeman RB; Hoy WE; Tibi PR; Carey AS
    N Y State J Med; 1982 Jul; 82(8):1199-206. PubMed ID: 6290953
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of a randomized monoclonal or polyclonal program of therapy on cytomegalovirus infection in kidney transplantation.
    Raffaele P; Pouteil-Noble C; Lefrancois N; Bosshard S; Betuel H; Aymard M; Dubernard JM; Touraine JL
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1361-2. PubMed ID: 1846465
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of HLA matching on graft survival and incidence and severity of graft rejection in cardiac transplantation.
    Suberbielle C; Dorent R; Vaissier E; Nataf P; Busson M; Cabrol A; Cabrol C; Charron D; Raffoux C; Gandjbakhch I
    Transplant Proc; 1994 Feb; 26(1):245-6. PubMed ID: 8108959
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of HLA matching in renal graft allocation.
    Shapira Z; Shmueli D; Bar-Nathan N; Lustig S; Nakache R; Sharabani E; Gayer E; Yussim A
    Transplant Proc; 1993 Dec; 25(6):3254-5. PubMed ID: 8266532
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of human leukocyte antigen compatibility and antibodies in liver transplantation in China.
    Meng XQ; Zhang X; Fan J; Zhou L; Hao B; Chen XM; Ma WH; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):141-5. PubMed ID: 19357026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of cytomegalovirus--imposed risks on the outcome of renal transplantation.
    Diosi P; Moldovan E; Rusinaru D
    Arch Roum Pathol Exp Microbiol; 1982; 41(1):35-41. PubMed ID: 6287964
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
    Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antirejection treatment in kidney transplantation--is there a proved rationale for the general use of monoclonal antibodies?
    Reis HJ; Hopt UT; Greger B; Schareck WD; Bockhorn H
    Transplant Proc; 1987 Oct; 19(5):3565-9. PubMed ID: 2823424
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal transplantation in HLA-identical sibling pairs.
    Dohi K; Fukuda Y; Asahara T; Tabe Y; Yahata H; Takenaka M; Ono E; Marubayashi S; Omotehara T; Eto T
    Hiroshima J Med Sci; 1984 Mar; 33(1):1-9. PubMed ID: 6384141
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk factors for chronic transplant failure after kidney transplantation.
    Hofmann GO; Schneeberger H; Land W
    Transplant Proc; 1995 Jun; 27(3):2031-2. PubMed ID: 7792875
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation.
    von Müller L; Schliep C; Storck M; Hampl W; Schmid T; Abendroth D; Mertens T
    J Med Virol; 2006 Mar; 78(3):394-9. PubMed ID: 16419118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ethnicity, donor status and HLA matching on renal allograft survival: a single center study.
    Chelluri LK; Vasantha A; Ratnakar KS
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):995-7. PubMed ID: 19861859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Panel reactive antibody screening and human leukocyte antigen typing in 1 700 cases of renal transplantation].
    Yu LX; Yao B; Ye GR; Du CF; Deng WF; Xu J; Ma JJ; Fu SJ; Xiao LL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):360-2. PubMed ID: 12390747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of cytomegalovirus (CMV) infections with increased recipient mortality following transplantation.
    Light JA; Burke DS
    Transplant Proc; 1979 Mar; 11(1):79-82. PubMed ID: 222022
    [No Abstract]   [Full Text] [Related]  

  • 18. Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients.
    Rook AH; Smith WJ; Burdick JF; Manischewitz JF; Frederick W; Siegel JP; Williams GM; Quinnan GV
    Transplant Proc; 1984 Dec; 16(6):1466-9. PubMed ID: 6095498
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytomegalovirus causing necrotizing laryngitis in a renal and cardiac transplant recipient.
    López-Amado M; Yebra-Pimentel MT; García-Sarandeses A
    Head Neck; 1996; 18(5):455-7; discussion 457-8. PubMed ID: 8864737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of renal transplantation in patients with primary cytomegalovirus infection.
    Pass RF; Whitley RJ; Diethelm AG; Whelchel JD; Reynolds DW; Alford CA
    Transplant Proc; 1979 Jun; 11(2):1288-90. PubMed ID: 224539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.